BIO vs FORM · rev $2.58B vs P/E 143, rev $763.6M
BIO (BIO) versus FormFactor Inc (FORM) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
FormFactor Inc (FORM) is a semiconductor equipment & materials company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported FORM revenue for 2024-12-28 was $763.6M. Net income was $69.6M. Revenue was up 15.2% from 2023-12-30 to 2024-12-28. FORM currently screens at market cap $9.71B and trailing P/E 143.2.
BIO currently screens at market cap $0. FORM currently screens at market cap $9.71B and trailing P/E 143.2.
Not investment advice. Open the BIO and FORM stock pages for the full models.
Not investment advice.